Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lemurs acquire drug-resistant bacteria by sharing environment with humans - study
Wild lemurs impacted by farming or tourism harboured more antibiotic-resistant microbes than those from more pristine enviornments.

The closer they live to people, the higher the proporation of antibiotic-resistant bacteria. 

Scientists have found antibiotic-resistant bacteria in the guts of lemurs living near humans.

The study, published in the journal Frontiers in Ecology & Evolution, suggests that the more human interaction they have, the more antibiotic-resistant bacteria they harbour.

Researchers hope their findings will have a positive impact on conservation and wildlife management practices.

Study co-author and graduate student Sally Bornbusch, from Duke University, North Carolina, said: “Humans came along, developed antibiotics, spread them all around us, and propagated these resistance genes into natural environments and into the microbiomes of wildlife. Even if these results are slightly scary, they help us use microbiome science to hone veterinary practices and conservation activities.

In the study, researchers sampled dung from ring-tailed lemurs, and sequenced the genes of all microbes found in the dung to find genetic markers for antibiotic resistance.
The project included 10 lemur populations from across Madagascar,  including seven from the wild, two from research facilities, and one kept as pets.

They found that the average proportion of antibiotic-resistant genes was 25 times higher in the guts of animals from research facilities than in wild animals, where the average amount was near zero. Interestingly, the figure was almost 35 times greater in lemurs kept as pets.

Researchers believe the increase in antibiotic-resistant bacteria in research lemurs is likely due to the good veterinary care they receive, giving them greater exposure to antibiotics than their wild cousins.

However, pet lemurs that likely never receive veterinary attention harboured the highest number of antibiotic-resistant genes. It is illegal to keep a lemur as a pet in Madagascar, so those that own them are unlikely to take them to a vet.

'These pet lemurs are therefore acquiring the antibiotic-resistant microbes simply by sharing their environment with humans and domestic animals,' researchers said.

Among the wild lemurs, antibiotic resistance varied depending on nearby human activity. Lemurs impacted by farming or tourism harboured more antibiotic-resistant microbes than those from more pristine environments, but still much less than lemurs living close to humans.

Bornbusch said that more research is needed to better understand the impact of these resistance genes on wildlife:

“Right now, we know that these resistance genes are out there, but we don’t know whether they are truly harmful to lemurs. These results give us a stepping-stone for research on the impact of these resistant microbes on wildlife and their environment.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.